The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Modelling the Impact of Antiretroviral Use in Resource-Poor Settings
Open accessAbstract
BACKGROUND: The anticipated scale-up of antiretroviral therapy (ART) in high-prevalence, resource-constrained settings requires operational research to guide policy on the design of treatment programmes. Mathematical models can explore the potential impacts of various treatment strategies, including timing of treatment initiation and provision of laboratory monitoring facilities, to complement evidence from pilot programmes. METHODS AND FINDINGS: A deterministic model of HIV transmission incorporating ART and stratifying infection progression into stages was constructed. The impact of ART was evaluated for various scenarios and treatment strategies, with different levels of coverage, patient eligibility, and other parameter values. These strategies included the provision of laboratory facilities that perform CD4 counts and viral load testing, and the timing of the stage of infection at which treatment is initiated. In our analysis, unlimited ART provision initiated at late-stage infection (AIDS) increased prevalence of HIV infection. The effect of additionally treating pre-AIDS patients depended on the behaviour change of treated patients. Different coverage levels for ART do not affect benefits such as life-years gained per person-year of treatment and have minimal effect on infections averted when treating AIDS patients only. Scaling up treatment of pre-AIDS patients resulted in more infections being averted per person-year of treatment, but the absolute number of infections averted remained small. As coverage increased in the models, the emergence and risk of spread of drug resistance increased. Withdrawal of failing treatment (clinical resurgence of symptoms), immunologic (CD4 count decline), or virologic failure (viral rebound) increased the number of infected individuals who could benefit from ART, but effectiveness per person is compromised. Only withdrawal at a very early stage of treatment failure, soon after viral rebound, would have a substantial impact on emergence of drug resistance. CONCLUSIONS: Our analysis found that ART cannot be seen as a direct transmission prevention measure, regardless of the degree of coverage. Counselling of patients to promote safe sexual practices is essential and must aim to effect long-term change. The chief aims of an ART programme, such as maximised number of patients treated or optimised treatment per patient, will determine which treatment strategy is most effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality associated with HIV infection in rural Rakai District, Uganda
Sewankambo, N. K., Gray, R. H., Ahmad, S., Serwadda, D., Wabwire-Mangen, F., Nalugoda, F., Kiwanuka, N., Lutalo, T., Kigozi, G., Li, C., et al. (2000) · AIDS · doi:10.1097/00002030-200010200-00021 · Cited by 149
Cited by
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Eaton, J. W., Johnson, L. F., Salomon, J. A., Bärnighausen, T., Bendavid, E., Bershteyn, A., Bloom, D. E., Cambiano, V., Fraser, C., Hontelez, J. A. C., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001245 · Cited by 395
Powers, K. A., Ghani, A. C., Miller, W. C., Hoffman, I. F., Pettifor, A. E., Kamanga, G., Martinson, F. E., & Cohen, M. S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60842-8 · Cited by 312
HIV treatment as prevention and HPTN 052
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f5cf2 · Cited by 301
Bennett, D. E., Myatt, M., Bertagnolio, S., Sutherland, D., & Gilks, C. F. (2008) · Antiviral Therapy · doi:10.1177/135965350801302s04 · Cited by 291
Metadata
- Authors
- Baggaley, R. F., Garnett, G. P., & Ferguson, N. M.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2006-03-14
- Volume
- 3
- Issue
- 4
- Pages
- e124
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2098729341
- Cited by
- 168
- References
- 1
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modelling the Impact of Antiretroviral Use in Resource-Poor Settings. https://app.cochat.ai/papers/10.1371/journal.pmed.0030124
- The paper
- Baggaley, R. F., Garnett, G. P., & Ferguson, N. M. (2006). Modelling the Impact of Antiretroviral Use in Resource-Poor Settings. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0030124
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.